Innovent Biologics (HK:1801) has released an update.
Innovent Biologics, Inc. has announced its current Board of Directors, comprised of executive and independent non-executive members, including Dr. De-Chao Michael Yu as Chairman and CEO. The company also outlined the composition of its four Board committees – Audit, Remuneration, Nomination, and Strategy – detailing the roles and chairmanships held by various directors.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.
